ZTS Q2 2019 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.5B+9.3% YoY

Gross Profit

$1.0B67.4% margin

Operating Income

$526M34.0% margin

Net Income

$371M24.0% margin

EPS (Diluted)

$0.77

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

$318M

Free Cash Flow

$215M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$11.0B

Total Liabilities

$8.6B

Stockholders' Equity

$2.4B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.4B	+9.3%
Gross Profit	$1.0B	$945M	+10.4%
Operating Income	$526M	$484M	+8.7%
Net Income	$371M	$384M	-3.4%

Revenue Segments

Dogs and Cats

$754M50%

Cattle

$379M25%

Swine

$158M11%

Poultry

$143M10%

Horses

$44M3%

Fish

$25M2%